The Law Office Of Joseph Klein Announces Investigation Of Possible Breach Of Fiduciary Duty By The Board Of Trubion Pharmaceuticals Inc. - TRBN
The Law Office of Joseph Klein is investigating the Board of Trubion Pharmaceuticals Inc. (NasdaqGM: TRBN) for possible breaches of fiduciary duty and other violations of state law regarding the sale of the company to Emergent BioSolutions Inc. (NYSE: EBS). Concerned shareholders should contact Joseph Klein directly at firstname.lastname@example.org, or toll-free at: (877) STOK-180 (877-786-5180).
Under the terms of the transaction, each share of Trubion common stock will be converted into the right to receive $1.365 per share in cash and 0.1641 shares of Emergent stock. Based on Emergent's common stock price for the prior five days, the transaction values Trubion stock at $4.55 per share and the transaction at approximately $96.8 million. In addition, Trubion shareholders will receive one contingent value right ("CVR") per share, which will entitle the holder to receive cash payments based upon the achievement of certain milestones. The total potential aggregate value of the CVRs is $38.7 million over a three year period.
The investigation concerns whether the Trubion Board of Directors breached their fiduciary duties to Trubion stockholders by failing to adequately shop the Company before entering into this transaction and whether Emergent is underpaying for Trubion shares. At least one analyst set a price target for Trubion stock at $7.00 per share.
If you own shares of Trubion and wish to obtain additional information about this investigation, please contact Joseph Klein, Esq. directly, via email at email@example.com, by telephone Toll Free: 877-STOK-180 (877-786-5180), or visit http://www.jkleinlawfirm.com/trubion-trbn.html.Joseph Klein, Esq. is an experienced attorney and has also practiced as a Certified Public Accountant. Mr. Klein represents investors and participates in securities litigations involving financial fraud throughout the nation. CONTACT: Joseph Klein, Esq.1560 East 27th StreetBrooklyn, NY 11229Telephone: (718) 947-0005Fax: (718) 799-1443Toll Free: (877) STOK-180 (877-786-5180) E-Mail: firstname.lastname@example.orgThe Web: www.jkleinlawfirm.com
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV